Market Research Logo

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, “Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides an overview of Prostate Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Prostate Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.Scope

  • Extensive coverage of the Prostate Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Prostate Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Prostate Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Prostate Cancer Diagnostic Tests Overview
  • Products under Development
    • Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of under Development
      • Table Figure 1: Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of under Development
      • Table Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of under Development
    • Prostate Cancer Diagnostic Tests - Pipeline Products by Territory
      • Table Figure 2: Prostate Cancer Diagnostic Tests - Pipeline Products by Territory
      • Table Prostate Cancer Diagnostic Tests - Pipeline Products by Territory
    • Prostate Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
      • Table Figure 3: Prostate Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
      • Table Prostate Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
    • Prostate Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Prostate Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
      • Table Prostate Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
    • Prostate Cancer Diagnostic Tests - Ongoing Clinical Trials
      • Table Figure 5: Prostate Cancer Diagnostic Tests - Ongoing Clinical Trials
      • Table Prostate Cancer Diagnostic Tests - Ongoing Clinical Trials
  • Prostate Cancer Diagnostic Tests - Pipeline Products under Development by Companies
    • Prostate Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
      • Table Prostate Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
    • Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of Development
      • Table Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of Development
  • Prostate Cancer Diagnostic Tests Companies and Product Overview
    • 3D Biomatrix LLC Company Overview
      • 3D Biomatrix LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3D Biomatrix LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3D Cell Assay - Metastatic Prostate Cancer - Product Status
        • Table 3D Cell Assay - Metastatic Prostate Cancer - Product Description
    • A&G Pharmaceutical Inc Company Overview
      • A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table A&G Pharmaceutical Inc Companion Diagnostic Test - Prostate Cancer - Product Status
        • Table A&G Pharmaceutical Inc Companion Diagnostic Test - Prostate Cancer - Product Description
    • Abnova Corp Company Overview
      • Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abnova Corp Biomarker Test - Prostate Cancer - Product Status
        • Table Abnova Corp Biomarker Test - Prostate Cancer - Product Description
    • AccuTech LLC Company Overview
      • AccuTech LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table AccuTech LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table PSA Test - Product Status
        • Table PSA Test - Product Description
    • Acobiom Company Overview
      • Acobiom Pipeline Products & Ongoing Clinical Trials Overview
        • Table Acobiom Pipeline Products & Ongoing Clinical Trials Overview
        • Table Companion Diagnostic Assay - Prostate Cancer - Product Status
        • Table Companion Diagnostic Assay - Prostate Cancer - Product Description
    • Adaptive Biotechnologies Corp Company Overview
      • Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ipilimumab Based Companion Diagnostic Test - Product Status
        • Table Ipilimumab Based Companion Diagnostic Test - Product Description
    • Advanced Marker Discovery SL Company Overview
      • Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table 2nd Generation Prostate Cancer Test - Product Status
        • Table 2nd Generation Prostate Cancer Test - Product Description
        • Table 3rd Generation Prostate Cancer Test - Product Status
        • Table 3rd Generation Prostate Cancer Test - Product Description
        • Table 4th Generation Prostate Cancer Test - Product Status
        • Table 4th Generation Prostate Cancer Test - Product Description
        • Table Advanced Marker Discovery SL Prognostic Test - Prostate Cancer - Product Status
        • Table Advanced Marker Discovery SL Prognostic Test - Prostate Cancer - Product Description
        • Table Urine Based Diagnostic Test - Prostate Cancer - Product Status
        • Table Urine Based Diagnostic Test - Prostate Cancer - Product Description
    • Affinimark Technologies, Inc. Company Overview
      • Affinimark Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Affinimark Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prostalent Diagnostic Test - Product Status
        • Table Prostalent Diagnostic Test - Product Description
    • AIT Austrian Institute of Technology GmbH Company Overview
      • AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table AIT Austrian Institute of Technology GmbH Biomarker Assay - Prostate Cancer - Product Status
        • Table AIT Austrian Institute of Technology GmbH Biomarker Assay - Prostate Cancer – Product Description
    • Albert Ludwigs University of Freiburg Company Overview
      • Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
        • Table Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
        • Table Urine Based Non-Invasive Prostate Cancer Assay - Product Status
        • Table Urine Based Non-Invasive Prostate Cancer Assay - Product Description
    • Alere Inc Company Overview
      • Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NMP48 Test - Product Status
        • Table NMP48 Test - Product Description
    • Almac Diagnostics Ltd Company Overview
      • Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prostate Cancer Metastatic Assay - Product Status
        • Table Prostate Cancer Metastatic Assay - Product Description
    • AltheaDx Inc Company Overview
      • AltheaDx Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AltheaDx Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AltheaDx Inc Prognostic Assay - Prostate Cancer - Product Status
        • Table AltheaDx Inc Prognostic Assay - Prostate Cancer - Product Description
    • Ambrilia Biopharma Inc Company Overview
      • Ambrilia Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ambrilia Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PSP94 Immunoassay - Product Status
        • Table PSP94 Immunoassay - Product Description
    • Andro Diagnostics (Inactive) Company Overview
      • Andro Diagnostics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Andro Diagnostics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Andro Diagnostics (Inactive) Diagnostic Test - Prostate Cancer - Product Status
        • Table Andro Diagnostics (Inactive) Diagnostic Test - Prostate Cancer - Product Description
    • ANGLE plc Company Overview
      • ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Parsortix-Based Test - Prostate Cancer - Product Status
        • Table Parsortix-Based Test - Prostate Cancer - Product Description
    • Armune BioScience Inc Company Overview
      • Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Armune BioScience Inc Diagnostic Test - Prostate Cancer - Product Status
        • Table Armune BioScience Inc Diagnostic Test - Prostate Cancer - Product Description
    • Arno Therapeutics Inc Company Overview
      • Arno Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arno Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Onapristone Companion Diagnostic Assay - Prostate Cancer - Product Status
        • Table Onapristone Companion Diagnostic Assay - Prostate Cancer - Product Description
    • Arquer Diagnostics Ltd Company Overview
      • Arquer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arquer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table UroSens Mcm5-ELISA Diagnostic Test - Prostate Cancer - Product Status
        • Table UroSens Mcm5-ELISA Diagnostic Test - Prostate Cancer - Product Description
        • Table Arquer Diagnostics Ltd - Ongoing Clinical Trials Overview
        • Table UroSens Mcm5-ELISA Diagnostic Test - Prostate Cancer - Study of Arquer's Mcm5-ELISA Test for Prostate Cancer
    • Arrayit Diagnostics, Inc. Company Overview
      • Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Microarray-Based Diagnostic Test - Prostate Cancer - Product Status
        • Table Microarray-Based Diagnostic Test - Prostate Cancer - Product Description
    • Atturos Company Overview
      • Atturos Pipeline Products & Ongoing Clinical Trials Overview
        • Table Atturos Pipeline Products & Ongoing Clinical Trials Overview
        • Table OCProDx - Product Status
        • Table OCProDx - Product Description
    • Aurelium BioPharma Inc. Company Overview
      • Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prostate Cancer Screening Test - Product Status
        • Table Prostate Cancer Screening Test - Product Description
    • Bayer HealthCare AG (Inactive) Company Overview
      • Bayer HealthCare AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bayer HealthCare AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table ODM-201 Based Companion Diagnostic Assay - Product Status
        • Table ODM-201 Based Companion Diagnostic Assay - Product Description
        • Table PSMA BiTE Antibody Based Companion Diagnostic Assay - Product Status
        • Table PSMA BiTE Antibody Based Companion Diagnostic Assay - Product Description
    • Baylor College of Medicine Company Overview
      • Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
        • Table Baylor College of Medicine Diagnostic Assay - Prostate Cancer - Product Status
        • Table Baylor College of Medicine Diagnostic Assay - Prostate Cancer - Product Description
    • Beckman Coulter Inc Company Overview
      • Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table UniCel DxC 600i Synchron Access BPH-A Assay - Product Status
        • Table UniCel DxC 600i Synchron Access BPH-A Assay - Product Description
    • BioAffinity Technologies, Inc. Company Overview
      • BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table CyPath Diagnostic Assay - Prostate Cancer - Product Status
        • Table CyPath Diagnostic Assay - Prostate Cancer - Product Description
    • Biocare Medical LLC Company Overview
      • Biocare Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biocare Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Clear View - Prostate Cancer - Product Status
        • Table Clear View - Prostate Cancer - Product Description
    • Biocrates Life Sciences AG Company Overview
      • Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metabolomic Biomarker Assay - Prostate Cancer - Product Status
        • Table Metabolomic Biomarker Assay - Prostate Cancer - Product Description
    • BioMark Diagnostics Inc. Company Overview
      • BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metabolomics-based Diagnostic Assay - Prostate Cancer - Product Status
        • Table Metabolomics-based Diagnostic Assay - Prostate Cancer - Product Description
    • bioMerieux S.A. Company Overview
      • bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
        • Table bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Annexin A3 Prostate Cancer Marker - Product Status
        • Table Annexin A3 Prostate Cancer Marker - Product Description
        • Table Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Status
        • Table Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Description
        • Table bioMerieux S.A Diagnostic Assay - Prostate Cancer - Product Status
        • Table bioMerieux S.A Diagnostic Assay - Prostate Cancer - Product Description
    • Bioprognos SL Company Overview
      • Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table MBDAA Prostate Cancer Test - Product Status
        • Table MBDAA Prostate Cancer Test - Product Description
    • Biosceptre International Ltd Company Overview
      • Biosceptre International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biosceptre International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prostate Cancer IHC Diagnostic Test - Product Status
        • Table Prostate Cancer IHC Diagnostic Test - Product Description
    • Biotron Ltd Company Overview
      • Biotron Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biotron Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table C-Test - Prostrate Cancer - Product Status
        • Table C-Test - Prostrate Cancer - Product Description
    • Blondin Bioscience, LLC Company Overview
      • Blondin Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blondin Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table FACT Assay - Metastatic Prostate Cancer - Product Status
        • Table FACT Assay - Metastatic Prostate Cancer - Product Description
    • Caldera Health Limited Company Overview
      • Caldera Health Limited Pipeline Products & Ongoing Clinical Trials Overview
        • Table Caldera Health Limited Pipeline Products & Ongoing Clinical Trials Overview
        • Table ProscaNZ - Product Status
        • Table ProscaNZ - Product Description
    • Cancer Research Technology Ltd Company Overview
      • Cancer Research Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cancer Research Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table IHC Based Test - Prostate Cancer - Product Status
        • Table IHC Based Test - Prostate Cancer - Product Description
    • Caris Life Sciences Inc Company Overview
      • Caris Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Caris Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - PSA - Product Status
        • Table Diagnostic Test - PSA - Product Description
    • Cellanyx Diagnostics, Inc. Company Overview
      • Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellanyx Test - Prostate Cancer - Product Status
        • Table Cellanyx Test - Prostate Cancer - Product Description
        • Table Cellanyx Diagnostics, Inc. - Ongoing Clinical Trials Overview
        • Table Cellanyx Test - Prostate Cancer - A Novel Live Cell Microfluidic Diagnostic Using Phenotypic Biomarkers with Objective Algorithmic Analysis for Prostate Cancer Risk Stratification
    • CellMax Life Company Overview
      • CellMax Life Pipeline Products & Ongoing Clinical Trials Overview
        • Table CellMax Life Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellmax - Prostate Cancer - Product Status
        • Table Cellmax - Prostate Cancer - Product Description
    • Cellmid Ltd Company Overview
      • Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table MK-ELISA Assay - Prostate Cancer - Product Status
        • Table MK-ELISA Assay - Prostate Cancer - Product Description
    • Cepheid Company Overview
      • Cepheid Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cepheid Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xpert Prostate CA Early Detection Test - Product Status
        • Table Xpert Prostate CA Early Detection Test - Product Description
        • Table Xpert Prostate Cancer Recurrence Risk Test - Product Status
        • Table Xpert Prostate Cancer Recurrence Risk Test - Product Description
    • Ceres Nanosciences Inc Company Overview
      • Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanotrap Prostate Cancer Biomarker Test - Product Status
        • Table Nanotrap Prostate Cancer Biomarker Test - Product Description
    • ChemImage Corp Company Overview
      • ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table ChemImage Corp Prognostic Test - Prostate Cancer - Product Status
        • Table ChemImage Corp Prognostic Test - Prostate Cancer - Product Description
    • Children's Hospital Boston Company Overview
      • Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
        • Table Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
        • Table Collagen XXIII Biomarker Assay - Prostate Cancer - Product Status
        • Table Collagen XXIII Biomarker Assay - Prostate Cancer - Product Description
    • China Sky One Medical Inc Company Overview
      • China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Kit - Human Prostate Specific Antigen - Product Status
        • Table Diagnostic Kit - Human Prostate Specific Antigen - Product Description
    • Chronix Biomedical Inc Company Overview
      • Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chronix Biomedical Inc Companion Diagnostic Test - Prostate Cancer - Product Status
        • Table Chronix Biomedical Inc Companion Diagnostic Test - Prostate Cancer - Product Description
    • Cleveland Diagnostics Inc. Company Overview
      • Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table IsoPSA Assay - Product Status
        • Table IsoPSA Assay - Product Description
        • Table Cleveland Diagnostics Inc. - Ongoing Clinical Trials Overview
        • Table IsoPSA Assay - Diagnostic Accuracy of Single-parameter, Structure-based IsoPSA Assay for
    • CompanDX Ltd. Company Overview
      • CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table CompanDX Ltd Biomarker Assay - Prostate Cancer - Product Status
        • Table CompanDX Ltd Biomarker Assay - Prostate Cancer - Product Description
    • Cornell University Company Overview
      • Cornell University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cornell University Pipeline Products & Ongoing Clinical Trials Overview
        • Table NEAT 1 Assay - Prostate Cancer - Product Status
        • Table NEAT 1 Assay - Prostate Cancer - Product Description
    • Courtagen Life Sciences Inc Company Overview
      • Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prostate Cancer Diagnostic Panel - Product Status
        • Table Prostate Cancer Diagnostic Panel - Product Description
    • CS-Keys, Inc. (Inactive) Company Overview
      • CS-Keys, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table CS-Keys, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table caPCNA - Prostate Cancer - Product Status
        • Table caPCNA - Prostate Cancer - Product Description
    • Cytosystems Ltd Company Overview
      • Cytosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cytosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table BladderLight - Prostate Cancer - Product Status
        • Table BladderLight - Prostate Cancer - Product Description
    • Dartmouth College Company Overview
      • Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview
        • Table ISH/IHC Assay - Prostate Cancer - Product Status
        • Table ISH/IHC Assay - Prostate Cancer - Product Description
    • Detroit R&D, Inc. Company Overview
      • Detroit R&D, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Detroit R&D, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oligosaccharide-Related Prostate Cancer Biomarker Assay - Product Status
        • Table Oligosaccharide-Related Prostate Cancer Biomarker Assay - Product Description
    • DiagnoCure Inc. (Inactive) Company Overview
      • DiagnoCure Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table DiagnoCure Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table PCP Risk Score Test - Product Status
        • Table PCP Risk Score Test - Product Description
    • Diaxonhit SA Company Overview
      • Diaxonhit SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diaxonhit SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table EHT Dx13 - Product Status
        • Table EHT Dx13 - Product Description
    • Emory University Company Overview
      • Emory University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Emory University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Emory University Diagnostic Test - Prostate Cancer - Product Status
        • Table Emory University Diagnostic Test - Prostate Cancer - Product Description
    • Epic Sciences Inc Company Overview
      • Epic Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Epic Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Epic AR-V7 Test - Product Status
        • Table Epic AR-V7 Test - Product Description
        • Table Epic Sciences Inc - Ongoing Clinical Trials Overview
        • Table Epic AR-V7 Test - Development of Circulating Molecular Predictors of Chemotherapy and Novel Hormonal Therapy Benefit in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC)
    • Epigenomics AG Company Overview
      • Epigenomics AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Epigenomics AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker mGSTP1 Prostate Cancer Test - Urine - Product Status
        • Table Biomarker mGSTP1 Prostate Cancer Test - Urine - Product Description
        • Table Biomarker PITX2 - Prostate Cancer Prognosis - Product Status
        • Table Biomarker PITX2 - Prostate Cancer Prognosis - Product Description
        • Table Screening And Monitoring Test - Prostate Cancer - Product Status
        • Table Screening And Monitoring Test - Prostate Cancer - Product Description
    • Euclid Diagnostics LLC Company Overview
      • Euclid Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Euclid Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Euclid Diagnostics LLC Diagnostic Test - Prostate Cancer - Product Status
        • Table Euclid Diagnostics LLC Diagnostic Test - Prostate Cancer - Product Description
    • Eventus Diagnostics Inc (Inactive) Company Overview
      • Eventus Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eventus Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Octava Test - Prostate Cancer - Product Status
        • Table Octava Test - Prostate Cancer - Product Description
    • Exiqon A/S Company Overview
      • Exiqon A/S Pipeline Products & Ongoing Clinical Trials Overview
        • Table Exiqon A/S Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Prostate Cancer Stratification - Product Status
        • Table Diagnostic Test - Prostate Cancer Stratification - Product Description
        • Table Prognosis Test - Prostate Cancer - Product Status
        • Table Prognosis Test - Prostate Cancer - Product Description
        • Table Prostate Cancer - Early Detection Test - Product Status
        • Table Prostate Cancer - Early Detection Test - Product Description
    • Exosomics Siena SpA Company Overview
      • Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table ExoTEST Prostate - Product Status
        • Table ExoTEST Prostate - Product Description
    • Fluxion Biosciences Inc Company Overview
      • Fluxion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fluxion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table IsoFlux CTC Liquid Biopsy System - Prostate Cancer - Product Status
        • Table IsoFlux CTC Liquid Biopsy System - Prostate Cancer - Product Description
    • Fred Hutchinson Cancer Research Center Company Overview
      • Fred Hutchinson Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fred Hutchinson Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Genomic Panel Prediction Test - Metastatic-Lethal Prostate Cancer - Product Status
        • Table Genomic Panel Prediction Test - Metastatic-Lethal Prostate Cancer - Product Description
    • French National Institute of Health and Medical Research Company Overview
      • French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table Protein Receptor Based Diagnostic Assay - Prostate Cancer - Product Status
        • Table Protein Receptor Based Diagnostic Assay - Prostate Cancer - Product Description
    • Genomic Health Inc Company Overview
      • Genomic Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Genomic Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Negative Biopsy Test - Prostate Cancer - Product Status
        • Table Negative Biopsy Test - Prostate Cancer - Product Description
        • Table Next Generation Sequencing Oncotype DX - Prostate Cancer Assay - Product Status
        • Table Next Generation Sequencing Oncotype DX - Prostate Cancer Assay - Product Description
    • Georgia Institute of Technology Company Overview
      • Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Biomarker Test - Prostate Cancer - Product Status
        • Table Diagnostic Biomarker Test - Prostate Cancer - Product Description
    • GILUPI Nanomedizin Company Overview
      • GILUPI Nanomedizin Pipeline Products & Ongoing Clinical Trials Overview
        • Table GILUPI Nanomedizin Pipeline Products & Ongoing Clinical Trials Overview
        • Table GILUPI Nanomedizin Diagnostic Test - Prostate Cancer - Product Status
        • Table GILUPI Nanomedizin Diagnostic Test - Prostate Cancer - Product Description
    • GlycoZym Company Overview
      • GlycoZym Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlycoZym Pipeline Products & Ongoing Clinical Trials Overview
        • Table GlycoZym Diagnostic Assay - Prostate Cancer - Product Status
        • Table GlycoZym Diagnostic Assay - Prostate Cancer - Product Description
    • Gregor Diagnostics Inc Company Overview
      • Gregor Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gregor Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Screening Test - Prostate Cancer - Product Status
        • Table Screening Test - Prostate Cancer - Product Description
    • Guangdong Medical College Company Overview
      • Guangdong Medical College Pipeline Products & Ongoing Clinical Trials Overview
        • Table Guangdong Medical College Pipeline Products & Ongoing Clinical Trials Overview
        • Table Optical Diagnostic Test - Prostate Cancer - Product Status
        • Table Optical Diagnostic Test - Prostate Cancer - Product Description
    • H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview
      • H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table H2AX Gene Based Diagnostic Test - Prostate Cancer - Product Status
        • Table H2AX Gene Based Diagnostic Test - Prostate Cancer - Product Description
        • Table H. Lee Moffitt Cancer Center & Research Institute Inc - Ongoing Clinical Trials Overview
        • Table H2AX Gene Based Diagnostic Test - Prostate Cancer - Assess Gamma H2ax Positivity in
    • Hologic Inc Company Overview
      • Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gene-Based Markers - Prostate Cancer - Product Status
        • Table Gene-Based Markers - Prostate Cancer - Product Description
        • Table Second-Generation Prostate Cancer Assay - Product Status
        • Table Second-Generation Prostate Cancer Assay - Product Description
    • Ikonisys Inc Company Overview
      • Ikonisys Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ikonisys Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table oncoFISH prostate - Product Status
        • Table oncoFISH prostate - Product Description
    • Imagion Biosystems Inc Company Overview
      • Imagion Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imagion Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MagSense Prostate Cancer Test - Product Status
        • Table MagSense Prostate Cancer Test - Product Description
    • Immunovia AB Company Overview
      • Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table IMMray - Prostate Cancer - Product Status
        • Table IMMray - Prostate Cancer - Product Description
    • Imperial College London Company Overview
      • Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biosensor Test - Product Status
        • Table Biosensor Test - Product Description
    • InterGenetics Inc Company Overview
      • InterGenetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table InterGenetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table OncoVue Prostate - Product Status
        • Table OncoVue Prostate - Product Description
    • IRIS International Inc Company Overview
      • IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NADIA - Prostate Cancer - Product Status
        • Table NADIA - Prostate Cancer - Product Description
    • IV Diagnostics Inc Company Overview
      • IV Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table IV Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Velox - Prostate Cancer - Product Status
        • Table Velox - Prostate Cancer - Product Description
    • Janssen Biotech Inc Company Overview
      • Janssen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Janssen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Janssen Biotech Inc Diagnostic Biomarker - Prostate Cancer - Product Status
        • Table Janssen Biotech Inc Diagnostic Biomarker - Prostate Cancer - Product Description
    • John Hopkins University Company Overview
      • John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table 5hmC Marker Assay - Prostate Cancer - Product Status
        • Table 5hmC Marker Assay - Prostate Cancer - Product Description
        • Table Biomarker Assay - Protein C Inhibitor - Product Status
        • Table Biomarker Assay - Protein C Inhibitor - Product Description
        • Table Blood Based Diagnostic Assay - Prostate Cancer - Product Status
        • Table Blood Based Diagnostic Assay - Prostate Cancer - Product Description
        • Table Diagnostic And Prognostic Assay - Aggressive Prostate Cancer - Product Status
        • Table Diagnostic And Prognostic Assay - Aggressive Prostate Cancer - Product Description
        • Table Protein Biomarker Assay - Aggressive Prostate Cancer - Product Status
        • Table Protein Biomarker Assay - Aggressive Prostate Cancer - Product Description
        • Table Serum-Based Assay - Prostate Cancer - Product Status
        • Table Serum-Based Assay - Prostate Cancer - Product Description
    • KineMed Inc Company Overview
      • KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Prostate Cell Proliferation - Product Status
        • Table Diagnostic Assay - Prostate Cell Proliferation - Product Description
    • King Abdullah University of Science and Technology Company Overview
      • King Abdullah University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table King Abdullah University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table King Abdullah University of Science and Technology Diagnostic Test - Prostate Cancer - Product Status
        • Table King Abdullah University of Science and Technology Diagnostic Test - Prostate Cancer – Product Description
    • Luminor Medical Technologies Inc Company Overview
      • Luminor Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Luminor Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Luminor Medical Technologies Inc Prostate Cancer Diagnostic Test - Product Status
        • Table Luminor Medical Technologies Inc Prostate Cancer Diagnostic Test - Product Description
    • MabCure Inc. Company Overview
      • MabCure Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table MabCure Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table MabCure Inc Diagnostic Test - Prostate Cancer - Product Status
        • Table MabCure Inc Diagnostic Test - Prostate Cancer - Product Description
    • MacroArray Technologies LLC Company Overview
      • MacroArray Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table MacroArray Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table HGPIN-1 - Product Status
        • Table HGPIN-1 - Product Description
        • Table PCADM-1 - Product Status
        • Table PCADM-1 - Product Description
        • Table PCADM-2 - Product Status
        • Table PCADM-2 - Product Description
    • Mayo Clinic US Company Overview
      • Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prostate Cancer Test - B7-H3 - Product Status
        • Table Prostate Cancer Test - B7-H3 - Product Description
    • MDNA Life Sciences Inc Company Overview
      • MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MDNA Life Sciences Inc Diagnostic Assay - Asymptomatic Prostate Cancer - Product Status
        • Table MDNA Life Sciences Inc Diagnostic Assay - Asymptomatic Prostate Cancer – Product Description
        • Table MDNA Life Sciences Inc Prognostic Test - Prostate Cancer - Product Status
        • Table MDNA Life Sciences Inc Prognostic Test - Prostate Cancer - Product Description
    • MDxHealth SA Company Overview
      • MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table InformMDx - Prostate Cancer CLIA Test - Product Status
        • Table InformMDx - Prostate Cancer CLIA Test - Product Description
        • Table RecurMDx - Prostate Cancer - Product Status
        • Table RecurMDx - Prostate Cancer - Product Description
    • Metabolomic Technologies Inc Company Overview
      • Metabolomic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metabolomic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ProstateDx - Product Status
        • Table ProstateDx - Product Description
    • Metanomics Health GmbH Company Overview
      • Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prognostic Assay - Prostate Cancer - Product Status
        • Table Prognostic Assay - Prostate Cancer - Product Description
    • MetaStat Inc Company Overview
      • MetaStat Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MetaStat Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MenaCalc Prostate - Product Status
        • Table MenaCalc Prostate - Product Description
    • Micromedic Technologies Ltd Company Overview
      • Micromedic Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micromedic Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table CellDetect - Prostate Cancer - Product Status
        • Table CellDetect - Prostate Cancer - Product Description
    • Milagen Inc Company Overview
      • Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Immunoassay - Prostate Cancer - Product Status
        • Table Immunoassay - Prostate Cancer - Product Description
    • Minomic International Ltd Company Overview
      • Minomic International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Minomic International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table MiCheck Prostate Cancer Test - Product Status
        • Table MiCheck Prostate Cancer Test - Product Description
        • Table Minomic International Ltd - Ongoing Clinical Trials Overview
        • Table MiCheck Prostate Cancer Test - A Prospective Study to Evaluate Accuracy and Reliability of MiCheck Prostate Cancer Test
    • Myriad Genetics Inc Company Overview
      • Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table myPath Prostate Cancer - Product Status
        • Table myPath Prostate Cancer - Product Description
    • Nano Discovery Inc. Company Overview
      • Nano Discovery Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nano Discovery Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table NanoDLSay - Prostate Cancer - Product Status
        • Table NanoDLSay - Prostate Cancer - Product Description
    • Nanocytomics LLC Company Overview
      • Nanocytomics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanocytomics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cancer Risk Stratification Test - Prostate Cancer - Product Status
        • Table Cancer Risk Stratification Test - Prostate Cancer - Product Description
    • NanoIVD Inc Company Overview
      • NanoIVD Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NanoIVD Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prostate CancerCheck - Product Status
        • Table Prostate CancerCheck - Product Description
    • Nanostics Inc Company Overview
      • Nanostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EV-FPS Test - Product Status
        • Table EV-FPS Test - Product Description
    • NeuroBioTex Inc Company Overview
      • NeuroBioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NeuroBioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prostate Cancer Home Screening Test - Product Status
        • Table Prostate Cancer Home Screening Test - Product Description
    • Northwestern University Company Overview
      • Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Northwestern University Biomarker Test - Prostate Cancer - Product Status
        • Table Northwestern University Biomarker Test - Prostate Cancer - Product Description
    • Novel Bio-spectrum Technologies Inc (Inactive) Company Overview
      • Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table NBT Diagnostic Test - Prostate Cancer - Product Status
        • Table NBT Diagnostic Test - Prostate Cancer - Product Description
    • Nuclea Biotechnologies Inc. (Inactive) Company Overview
      • Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Decision Dx - Prostate Cancer - Product Status
        • Table Decision Dx - Prostate Cancer - Product Description
        • Table USP2a Diagnostic Assay - Prostate Cancer - Product Status
        • Table USP2a Diagnostic Assay - Prostate Cancer - Product Description
    • Numares AG Company Overview
      • Numares AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Numares AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table AXINON Test - Prostate Cancer - Product Status
        • Table AXINON Test - Prostate Cancer - Product Description
    • NuView Life Sciences Inc Company Overview
      • NuView Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NuView Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table VPAC1 Urinary Assay - Prostate Cancer - Product Status
        • Table VPAC1 Urinary Assay - Prostate Cancer - Product Description
        • Table NuView Life Sciences Inc - Ongoing Clinical Trials Overview
        • Table VPAC1 Urinary Assay - Prostate Cancer - Clinical Utility of VPAC1 Urinary Assay for the Detection of Prostate and Bladder Cancers
    • Olympia Diagnostics, Inc Company Overview
      • Olympia Diagnostics, Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Olympia Diagnostics, Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PCa-Dx - Product Status
        • Table PCa-Dx - Product Description
        • Table PCa-Mx - Product Status
        • Table PCa-Mx - Product Description
        • Table PCa-Px - Product Status
        • Table PCa-Px - Product Description
        • Table PCa-Sx - Product Status
        • Table PCa-Sx - Product Description
        • Table PCa-Tx - Product Status
        • Table PCa-Tx - Product Description
    • Onconome, Inc. (Inactive) Company Overview
      • Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table ProstaMark EPCA Tissue Assay - Product Status
        • Table ProstaMark EPCA Tissue Assay - Product Description
        • Table ProstaMark EPCA-2 Serum Assay - Product Status
        • Table ProstaMark EPCA-2 Serum Assay - Product Description
    • ONCOVEDA Cancer Research Center Company Overview
      • ONCOVEDA Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table ONCOVEDA Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table ONCOVEDA Cancer Research Center Diagnostic Test - Prostate Cancer - Product Status
        • Table ONCOVEDA Cancer Research Center Diagnostic Test - Prostate Cancer - Product Description
    • OncoVista Innovative Therapies Inc Company Overview
      • OncoVista Innovative Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table OncoVista Innovative Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table OVI-117 Biomarker - Prostate Cancer - Product Status
        • Table OVI-117 Biomarker - Prostate Cancer - Product Description
    • On-Q-ity, Inc. (Inactive) Company Overview
      • On-Q-ity, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table On-Q-ity, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dual-Capture Microfluidic Chip - Prostate Cancer - Product Status
        • Table Dual-Capture Microfluidic Chip - Prostate Cancer - Product Description
    • Ontario Institute for Cancer Research Company Overview
      • Ontario Institute for Cancer Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ontario Institute for Cancer Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table Liquid Biopsy Test - Prostate Cancer - Product Status
        • Table Liquid Biopsy Test - Prostate Cancer - Product Description
    • Orion Genomics LLC Company Overview
      • Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orion Genomics LLC Diagnostic Test - Prostate Cancer - Product Status
        • Table Orion Genomics LLC Diagnostic Test - Prostate Cancer - Product Description
    • Ortho-Clinical Diagnostics Inc Company Overview
      • Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ProMu - Product Status
        • Table ProMu - Product Description
    • Oryzon Genomics SA Company Overview
      • Oryzon Genomics SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oryzon Genomics SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table OG-px - Product Status
        • Table OG-px - Product Description
        • Table Oryzon Diagnostic Test - Prostate Cancer - Product Status
        • Table Oryzon Diagnostic Test - Prostate Cancer - Product Description
    • OTraces Inc. Company Overview
      • OTraces Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table OTraces Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table PR Sera Dx - Product Status
        • Table PR Sera Dx - Product Description
    • Panacea Pharmaceuticals Inc Company Overview
      • Panacea Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Panacea Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PC Detect - Product Status
        • Table PC Detect - Product Description
    • PharmaSeq Inc Company Overview
      • PharmaSeq Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PharmaSeq Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Multiplex Prostate Cancer Serum Assay - Product Status
        • Table Multiplex Prostate Cancer Serum Assay - Product Description
    • Precision Biologics Inc Company Overview
      • Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Prostate Cancer - Product Status
        • Table Diagnostic Assay - Prostate Cancer - Product Description
    • Predictive Biosciences Inc Company Overview
      • Predictive Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Predictive Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnsotic Triage Test - Prostate Cancer - Product Status
        • Table Diagnsotic Triage Test - Prostate Cancer - Product Description
        • Table Predictive Biosciences Inc Prognostic Assay - Prostate Cancer - Product Status
        • Table Predictive Biosciences Inc Prognostic Assay - Prostate Cancer - Product Description
    • PrognosDx Health Inc Company Overview
      • PrognosDx Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PrognosDx Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PrognoScore Test - Prostate Cancer - Product Status
        • Table PrognoScore Test - Prostate Cancer - Product Description
    • Prostate Management Diagnostics Inc Company Overview
      • Prostate Management Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prostate Management Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Prostate Cancer Monitoring - Product Status
        • Table Diagnostic Assay - Prostate Cancer Monitoring - Product Description
        • Table Diagnostic Test - Indolent And Aggressive Prostate Cancer - Product Status
        • Table Diagnostic Test - Indolent And Aggressive Prostate Cancer - Product Description
    • Protagen AG Company Overview
      • Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Protagen AG Diagnostic Assay - Prostate Cancer - Product Status
        • Table Protagen AG Diagnostic Assay - Prostate Cancer - Product Description
    • Proteocyte Diagnostics Inc Company Overview
      • Proteocyte Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Proteocyte Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Molecular Diagnostic Test - Prostate Cancer - Product Status
        • Table Molecular Diagnostic Test - Prostate Cancer - Product Description
    • ProteoMediX AG Company Overview
      • ProteoMediX AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table ProteoMediX AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table ProteoMediX AG Diagnostic Test - Prostate Cancer - Product Status
        • Table ProteoMediX AG Diagnostic Test - Prostate Cancer - Product Description
        • Table Prostate Cancer Prognosis Assay - Product Status
        • Table Prostate Cancer Prognosis Assay - Product Description
        • Table Prostate Cancer Stratification Assay - Product Status
        • Table Prostate Cancer Stratification Assay - Product Description
        • Table ProteoMediX Prostate Cancer Test - Product Status
        • Table ProteoMediX Prostate Cancer Test - Product Description
    • Proteomika Company Overview
      • Proteomika Pipeline Products & Ongoing Clinical Trials Overview
        • Table Proteomika Pipeline Products & Ongoing Clinical Trials Overview
        • Table Proteomika Biomarker Test - Prostate Cancer - Product Status
        • Table Proteomika Biomarker Test - Prostate Cancer - Product Description
    • Proveri Inc. (Inactive) Company Overview
      • Proveri Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Proveri Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Proveri Inc. (Inactive)Companion Diagnostic Test - Prostate Cancer - Product Status
        • Table Proveri Inc. (Inactive)Companion Diagnostic Test - Prostate Cancer - Product Description
        • Table Proveri Diagnostic Test - Prostate Cancer - Product Status
        • Table Proveri Diagnostic Test - Prostate Cancer - Product Description
        • Table Proveri Prognostic Test - Prostate Cancer - Product Status
        • Table Proveri Prognostic Test - Prostate Cancer - Product Description
    • Qiagen NV Company Overview
      • Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table AR-V7 Companion Diagnostic Test - Product Status
        • Table AR-V7 Companion Diagnostic Test - Product Description
    • Quanterix Corp Company Overview
      • Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table AccuPSA Test - Product Status
        • Table AccuPSA Test - Product Description
        • Table SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Status
        • Table SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Description
    • Rappaport Family Institute for Research in the Medical Science Company Overview
      • Rappaport Family Institute for Research in the Medical Science Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rappaport Family Institute for Research in the Medical Science Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rappaport Family Institute for Research in the Medical Science Biomarker Test – Prostate Cancer - Product Status
        • Table Rappaport Family Institute for Research in the Medical Science Biomarker Test – Prostate Cancer - Product Description
    • RiboMed Biotechnologies Inc Company Overview
      • RiboMed Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RiboMed Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prostate Cancer Assay - Product Status
        • Table Prostate Cancer Assay - Product Description
    • Roche Diagnostics International Ltd Company Overview
      • Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Anti-STEAP1 ADC Companion Diagnostic Test - Product Status
        • Table Anti-STEAP1 ADC Companion Diagnostic Test - Product Description
    • Roswell Park Cancer Institute Company Overview
      • Roswell Park Cancer Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Roswell Park Cancer Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Roswell Park Cancer Institute Biomarker Test - Prostate Cancer - Product Status
        • Table Roswell Park Cancer Institute Biomarker Test - Prostate Cancer - Product Description
    • Siamab Therapeutics Inc Company Overview
      • Siamab Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Siamab Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Auto Antibody-Based Prostate Cancer Test - Product Status
        • Table Auto Antibody-Based Prostate Cancer Test - Product Description
    • Siemens Healthcare GmbH Company Overview
      • Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table ADVIA Centaur CP Immunoassay System - Free PSA Assay - Product Status
        • Table ADVIA Centaur CP Immunoassay System - Free PSA Assay - Product Description
    • Sienna Cancer Diagnostics Ltd Company Overview
      • Sienna Cancer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sienna Cancer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Telomerase Test - Prostate Cancer - Product Status
        • Table Telomerase Test - Prostate Cancer - Product Description
    • Sividon Diagnostics GmbH Company Overview
      • Sividon Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sividon Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sividon Diagnostics GmbH Diagnostic Assay - Prostate Cancer - Product Status
        • Table Sividon Diagnostics GmbH Diagnostic Assay - Prostate Cancer - Product Description
    • Soricimed Biopharma Inc Company Overview
      • Soricimed Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Soricimed Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic SOR-D01 Assay - Prostate Cancer - Product Status
        • Table Diagnostic SOR-D01 Assay - Prostate Cancer - Product Description
        • Table Diagnostic SOR-D02 Assay - Prostate Cancer - Product Status
        • Table Diagnostic SOR-D02 Assay - Prostate Cancer - Product Description
    • Source MDx Company Overview
      • Source MDx Pipeline Products & Ongoing Clinical Trials Overview
        • Table Source MDx Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aggressive Cancer Stratification - Prostate Cancer - Product Status
        • Table Aggressive Cancer Stratification - Prostate Cancer - Product Description
        • Table Avastin-Predicitve Response - Prostate Cancer - Product Status
        • Table Avastin-Predicitve Response - Prostate Cancer - Product Description
    • Stage I Diagnostics Inc Company Overview
      • Stage I Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stage I Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table P-TAB Test - Product Status
        • Table P-TAB Test - Product Description
    • Target Discovery Inc (Inactive) Company Overview
      • Target Discovery Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Target Discovery Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Isonostic Assay - Prostate Cancer - Product Status
        • Table Isonostic Assay - Prostate Cancer - Product Description
    • The University of South Australia Company Overview
      • The University of South Australia Pipeline Products & Ongoing Clinical Trials Overview
        • Table The University of South Australia Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Prostate Cancer - Product Status
        • Table Diagnostic Assay - Prostate Cancer - Product Description
    • Thermo Fisher Scientific Inc Company Overview
      • Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stockholm3 test - Product Status
        • Table Stockholm3 test - Product Description
    • TRACON Pharmaceuticals Inc Company Overview
      • TRACON Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TRACON Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Companion Diagnostic Test - TRC253 - Product Status
        • Table Companion Diagnostic Test - TRC253 - Product Description
    • Tyrian Diagnostics Ltd Company Overview
      • Tyrian Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tyrian Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tyrian Diagnostics Ltd Prostate Cancer Diagnostic Test - Product Status
        • Table Tyrian Diagnostics Ltd Prostate Cancer Diagnostic Test - Product Description
    • University College Dublin Company Overview
      • University College Dublin Pipeline Products & Ongoing Clinical Trials Overview
        • Table University College Dublin Pipeline Products & Ongoing Clinical Trials Overview
        • Table MRM Based Biomarker Assay - Prostate Cancer - Product Status
        • Table MRM Based Biomarker Assay - Prostate Cancer - Product Description
    • University of Arizona Company Overview
      • University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Arizona Diagnostic Assay - Prostate Cancer - Product Status
        • Table University of Arizona Diagnostic Assay - Prostate Cancer - Product Description
    • University of California Los Angeles Company Overview
      • University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
        • Table A+PSA Assay - Product Status
        • Table A+PSA Assay - Product Description
    • University of Central Florida Company Overview
      • University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Central Florida Diagnostic Assay - Prostate Cancer - Product Status
        • Table University of Central Florida Diagnostic Assay - Prostate Cancer - Product Description
    • University of Chicago Company Overview
      • University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
        • Table IRDS Predictive Marker - Prostate Cancer - Product Status
        • Table IRDS Predictive Marker - Prostate Cancer - Product Description
    • University of Colorado Company Overview
      • University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antibody Tethering Technology Based Immunoassay - Prostate Cancer - Product Status
        • Table Antibody Tethering Technology Based Immunoassay - Prostate Cancer - Product Description
    • University of Connecticut Company Overview
      • University of Connecticut Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Connecticut Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Panel - Prostate Cancer - Product Status
        • Table Biomarker Panel - Prostate Cancer - Product Description
    • University of Gottingen Company Overview
      • University of Gottingen Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Gottingen Pipeline Products & Ongoing Clinical Trials Overview
        • Table miRNA Biomarker Diagnostic Test - Prostate Cancer - Product Status
        • Table miRNA Biomarker Diagnostic Test - Prostate Cancer - Product Description
    • University of Iowa Company Overview
      • University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prognostic Assay - Prostate Cancer - Product Status
        • Table Prognostic Assay - Prostate Cancer - Product Description
    • University of Malaya Company Overview
      • University of Malaya Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Malaya Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Malaya Biomarker Test - Prostate Cancer - Product Status
        • Table University of Malaya Biomarker Test - Prostate Cancer - Product Description
    • University of Maryland Baltimore Company Overview
      • University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prognostic Biomarker Test - Prostate Cancer - Product Status
        • Table Prognostic Biomarker Test - Prostate Cancer - Product Description
    • University of Michigan Company Overview
      • University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Michigan Diagnostic Test - Prostate Cancer - Product Status
        • Table University of Michigan Diagnostic Test - Prostate Cancer - Product Description
    • University of Oslo Company Overview
      • University of Oslo Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Oslo Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Prostate Cancer - Product Status
        • Table Diagnostic Test - Prostate Cancer - Product Description
    • University of Otago Company Overview
      • University of Otago Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Otago Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Otago Diagnostic Test - Prostate Cancer - Product Status
        • Table University of Otago Diagnostic Test - Prostate Cancer - Product Description
    • University of South Florida Company Overview
      • University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bif-1 Based Diagnostic Assay - Prostate Cancer - Product Status
        • Table Bif-1 Based Diagnostic Assay - Prostate Cancer - Product Description
    • University of Strathclyde Company Overview
      • University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Strathclyde Diagnostic Biomarker - Prostate Cancer - Product Status
        • Table University of Strathclyde Diagnostic Biomarker - Prostate Cancer - Product Description
    • University of Washington Company Overview
      • University of Washington Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Washington Pipeline Products & Ongoing Clinical Trials Overview
        • Table High Intensity Focused Ultrasound (HIFU) - Blood-Based Biomarker Test - Product Status
        • Table High Intensity Focused Ultrasound (HIFU) - Blood-Based Biomarker Test - Product Description
    • Uppsala University Company Overview
      • Uppsala University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Uppsala University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prostate Cancer Diagnostic Marker - Product Status
        • Table Prostate Cancer Diagnostic Marker - Product Description
    • US Biomarkers Inc Company Overview
      • US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood-Based Biomarker - Prostate Cancer - Product Status
        • Table Blood-Based Biomarker - Prostate Cancer - Product Description
    • Vermillion Inc Company Overview
      • Vermillion Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vermillion Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vermillion Inc Biomarker Test - Prostate Cancer - Product Status
        • Table Vermillion Inc Biomarker Test - Prostate Cancer - Product Description
        • Table ProstaCheck - Product Status
        • Table ProstaCheck - Product Description
    • Vitatex Inc. Company Overview
      • Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prostate Cancer CTC Detection Kit - Product Status
        • Table Prostate Cancer CTC Detection Kit - Product Description
    • Vitrimark Inc (Inactive) Company Overview
      • Vitrimark Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vitrimark Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Structural Biomarker Assay - Prostate Cancer - Product Status
        • Table Structural Biomarker Assay - Prostate Cancer - Product Description
    • Vitruvian Biomedical Inc Company Overview
      • Vitruvian Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vitruvian Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vitruvian Biomedical Inc Diagnostic Assay - Prostate Cancer - Product Status
        • Table Vitruvian Biomedical Inc Diagnostic Assay - Prostate Cancer - Product Description
    • VolitionRX Ltd Company Overview
      • VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NuQ - Prostate Cancer - Product Status
        • Table NuQ - Prostate Cancer - Product Description
        • Table VolitionRX Ltd - Ongoing Clinical Trials Overview
        • Table NuQ - Prostate Cancer - A Retrospective Study to Establish the Efficacy of VolitionRx's NuQ Test to Distinguish Anaplastic Prostate Cancer
        • Table NuQ - Prostate Cancer - Multicenter study to evaluate ability of NuQ to detect prostate cancer
    • ZEUS Scientific Inc Company Overview
      • ZEUS Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ZEUS Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EN2 Urine Test - Prostate Cancer - Product Status
        • Table EN2 Urine Test - Prostate Cancer - Product Description
  • Prostate Cancer Diagnostic Tests - Recent Developments
    • Sep 13, 2017: HIFU for Prostate Cancer now Available at North Carolina Specialty Hospital in Durham, North Carolina
    • Sep 06, 2017: MDxHealth Prepares for Growth with Executive Team Expansion
    • Sep 06, 2017: Sandra Cole Appointed Vice President and Chief Compliance Officer for OPKO's BioReference Laboratories
    • Sep 01, 2017: Aeterna Zentaris Announces Departure of Vice President, Finance & Chief Accounting Officer
    • Aug 31, 2017: MDxHealth Announces First Half 2017 Financial Results
    • Aug 31, 2017: EDAP Partners with Leading US HIFU provider, Vituro Health Adds Ablatherm Robotic HIFU
    • Aug 31, 2017: Sienna Cancer Diagnostics: Appendix 4E & 2017 Financial Report Release
    • Aug 30, 2017: bioMerieux – First-Half 2017 Results
    • Aug 24, 2017: AroCell: Interim report, Q2 2017
    • Aug 24, 2017: New imaging technique spots prostate tumours starved of oxygen
    • Aug 22, 2017: Blood Test Predicts Prostate Tumor Resistance
    • Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers
    • Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories
    • Aug 16, 2017: Dr. Jatin P. Shah, International Leader in Head and Neck Surgery, joins Proteocyte Diagnostics' Clinical Advisory Board
    • Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update
    • Aug 14, 2017: Cancer Genetics Announces Second Quarter 2017 Financial Results, Accretive Acquisition and Capital Raise
    • Aug 10, 2017: ConfirmMDx Study Provides Further Validation of Epigenetic Risk Profile
    • Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results
    • Aug 10, 2017: Aeterna Zentaris Reports Second Quarter 2017 Financial and Operating Results
    • Aug 09, 2017: Geron Reports Second Quarter 2017 Financial Results
    • Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update
    • Aug 08, 2017: MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
    • Aug 08, 2017: OPKO Health Reports Second Quarter 2017 Business and Financial Results
    • Aug 07, 2017: MDxHealth Appoints Seasoned EVP to Lead Sales Force Expansion
    • Aug 07, 2017: First Human Application of Novel PET Tracer for Prostate Cancer
    • Aug 03, 2017: Exosome Diagnostics Achieves ISO 13485 Certification
    • Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017
    • Aug 01, 2017: Genomic Health Announces Second Quarter 2017 Financial Results and Reports Recent Business Progress
    • Aug 01, 2017: Exosome Diagnostics Announces New World Headquarters and Laboratory in Waltham, MA
    • Jul 28, 2017: ORYZON Reports Financial Results and Corporate Update for the 1st Half Ended June 30, 2017
    • Jul 27, 2017: Adaptive Biotechnologies Expands Leadership to Bolster Integration of Immune Profiling into Clinical Care Setting
    • Jul 27, 2017: Ipsen Delivers Strong Sales Growth of 18.8% in the First Half of 2017 and Upgrades Its Guidance for Full Year 2017
    • Jul 27, 2017: QIAGEN Reports Results for Second Quarter and First Half of 2017
    • Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook
    • Jul 25, 2017: NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017
    • Jul 20, 2017: bioMerieux – Second-Quarter 2017 Business Review
    • Jul 20, 2017: Aeterna Zentaris Forms Strategic Review Committee and Appoints Michael Ward as CEO
    • Jul 18, 2017: Minomic Launches US Prospective Study of MiCheck Prostate Cancer Test
    • Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results
    • Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology
    • Jul 10, 2017: Novus Therapeutics Announces Change in Management
    • Jul 06, 2017: Epigenomics issues change in guidance for financial year 2017
    • Jun 30, 2017: GeneNews Announces Election of Directors
    • Jun 29, 2017: Study Used Iso-Seq Method to Unravel Activity of Receptors in Prostate Cancer
    • Jun 21, 2017: Immunodiagnostic Systems Holdings: Final Results for year ended 31 March 2017
    • Jun 21, 2017: Dr. Helge Lubenow elected as a new member to the Board of Directors
    • Jun 19, 2017: New three-in-one blood test opens door to precision medicine for prostate cancer
    • Jun 19, 2017: MetaStat Announces Completion of Second Milestone of its Pilot Research Project with Celgene
    • Jun 15, 2017: Parsortix Breakthrough Delivers Rare Blood Cell Discovery in Prostate Cancer
    • Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation
    • Jun 12, 2017: Novus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    • Jun 09, 2017: New blood test uses nanotechnology to predict aggressive prostate cancer accurately
    • Jun 08, 2017: Siamab Therapeutics to Present at the 2017 BIO International Convention
    • Jun 07, 2017: Almac Group Reports Pre-tax Profits of £27M
    • Jun 02, 2017: Genomic Health Presents Data Further Demonstrating Ability of Oncotype DX Tests to Optimize Outcomes in Patients Across Cancer Types
    • Jun 02, 2017: Cancer Genetics to Present at the 7th Annual LD Micro Invitational
    • Jun 01, 2017: GenomeDx's Decipher to be Featured in Multiple Presentations at ASCO 2017
    • May 18, 2017: OPKO Health's 4Kscore Test Highlighted in Podium Presentation at 112th American Urological Association Annual Meeting
    • May 17, 2017: Caris Life Sciences Appoints John Marshall, M.D., as Chief Medical Officer
    • May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors
    • May 16, 2017: Oryzon announces appointment of new Chief Medical Officer and expansion of its Medical Department
    • May 15, 2017: OPKO Announces Multiple Presentations at the 112th American Urological Association Annual Meeting
    • May 15, 2017: NeoGenomics Reports that its NeoLAB Liquid Biopsy Prostate Test is More Accurate than Conventional Biopsies in Predicting High Grade Prostate Cancer
    • May 15, 2017: Cleveland Diagnostics Announces Preliminary Results from Multicenter IsoPSA Study Demonstrating Significantly Improved Accuracy Over Standard Prostate-Specific Antigen Test
    • May 15, 2017: New blood test is more accurate in predicting prostate cancer risk than PSA
    • May 12, 2017: ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
    • May 11, 2017: Cancer Genetics Announces 15% Revenue Increase in First Quarter of 2017 over 2016 on Strong Organic Growth While Continuing on Path to Profitability
    • May 11, 2017: GenomeDx's Decipher GRID Aids in Development and Validation of Molecular Subtypes in Prostate Cancer that Predict Response to Hormone Therapy
    • May 11, 2017: Biocept Reports First Quarter 2017 Financial Results
    • May 11, 2017: VolitionRx Announces First Quarter 2017 Financial Results and Business Update
    • May 11, 2017: Vermillion Reports First Quarter 2017 Results
    • May 11, 2017: GeneNews Announces Q1-2017 Financial Results & Provides Progress Update
    • May 10, 2017: Epigenomics announces 2017 First Quarter Financial Results
    • May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017
    • May 09, 2017: OPKO Health Reports 2016 Financial and Operating Results
    • May 09, 2017: Geron Reports First Quarter 2017 Financial Results and Recent Events
    • May 09, 2017: ORYZON Reports Financial Results and Corporate Update for the 1st Quarter, 2017
    • May 09, 2017: GenomeDx Appoints Michael Rodriguez as Chief Financial Officer
    • May 09, 2017: Genomic Health Announces First Quarter 2017 Financial Results and Reports Recent Business Progress
    • May 08, 2017: MDxHealth Trading Update: January to April 2017
    • May 08, 2017: Aeterna Zentaris Reports First Quarter 2017 Financial and Operating Results
    • May 08, 2017: MetaStat Elevates Jerome B. Zeldis, M.D., Ph.D. to Chairman of the Board and Appoints Douglas A. Hamilton, MetaStat's President and CEO to its Board of Directors
    • May 03, 2017: New blood test predicts who will benefit from targeted prostate cancer treatments
    • May 02, 2017: MDxHealth Announces New Contract Regarding ConfirmMDx with MediNcrease Health Plans Regarding ConfirmMDx
    • May 02, 2017: QIAGEN reports results for first quarter 2017
    • May 02, 2017: Myriad Genetics Reports Fiscal Third-Quarter 2017 Financial Results
    • Apr 27, 2017: Ipsen Reports Strong First Quarter 2017 Sales Growth of 19,1%1
    • Apr 26, 2017: NeoGenomics Reports 15% Volume Growth and 10% Reduction in Average Cost per Test in the First Quarter of 2017
    • Apr 26, 2017: Epigenomics Reports Results for Financial Year 2016
    • Apr 20, 2017: Almac Group Announces Publication of Prostate Cancer Metastatic Assay Validation
    • Apr 20, 2017: Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook
    • Apr 20, 2017: NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development
    • Apr 20, 2017: bioMerieux – First-Quarter 2017 Business Review
    • Apr 19, 2017: Johnson & Johnson reports Q1 2017 results
    • Apr 19, 2017: New CEO Appointed From Within Sienna
    • Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results
    • Apr 17, 2017: Biomerica Announces Third Quarter Financial Results, Sales up 13.9% for Nine Months
    • Apr 14, 2017: Ipsen appoints Dr. Alexandre Lebeaut as Executive Vice-President, R&D, and Chief Scientific Officer
    • Apr 12, 2017: Roche launches antibody test to aid in diagnosis of challenging prostate cancer cases
    • Apr 11, 2017: VolitionRx Appoints David Vanston as Chief Financial Officer
    • Apr 03, 2017: GeneNews Announces Fourth Quarter and Full Year 2016 Financial Results
    • Mar 30, 2017: Angle Announces Potential for Prediction of Metastasis in Prostate Cancer
    • Mar 30, 2017: Swedish prostate cancer test to be introduced in Europe
    • Mar 29, 2017: Vermillion Reports Fourth Quarter and Full Year 2016 Results
    • Mar 27, 2017: MDxHealth Epigenetic Biomarkers Identify Men at Increased Risk of Prostate Cancer Recurrence
    • Mar 27, 2017: Recent Clinical Study Results of ProteoMediX' Prostate Cancer Test Presented at the 2017 Annual European Association of Urology Congress
    • Mar 23, 2017: Cancer Genetics Announces Record Revenue for Fourth Quarter and Full-Year 2016 and Provides 2017 Business Update
    • Mar 21, 2017: Caris Life Sciences Announces Presentations at AACR 2017 Annual Meeting Demonstrating the Broad Capabilities of ADAPT Biotargeting System
    • Mar 16, 2017: Nynex Therapeutics Launched to Target Oncogenic Proteins in the Treatment of Cancer
    • Mar 15, 2017: Aeterna Zentaris Reports Fourth Quarter and Full-Year 2016 Financial and Operating Results
    • Mar 13, 2017: Cancer Genetics to Present at "A Future Without Cancer Conference" on Friday, March 17
    • Mar 13, 2017: Immunodiagnostic Systems Holdings Re-Appoints CEO
    • Mar 10, 2017: VolitionRx Announces Full Fiscal Year 2016 Financial Results and Business Update
    • Mar 03, 2017: OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development
    • Mar 02, 2017: Ipsen appoints Benoit Hennion as Executive Vice President and President, Primary Care
    • Mar 01, 2017: Arquer Diagnostics awarded funding under Innovate UK's Biocatalyst programme
    • Mar 01, 2017: OPKO Health Reports 2016 Financial and Operating Results
    • Mar 01, 2017: Geron Reports Fourth Quarter and Annual 2016 Financial Results
    • Mar 01, 2017: bioMerieux – 2016 Financial Results
    • Feb 24, 2017: ORYZON Reports Financial Results and Corporate Update for the Fourth Quarter and Year Ended December 31, 2016
    • Feb 24, 2017: Immunodiagnostic Systems Holdings: Update on CEO Appointment
    • Feb 23, 2017: Ipsen delivers strong 2016 results and expects further sales growth and margin enhancement for 2017
    • Feb 23, 2017: MDxHealth Reports Financial Year 2016 Results
    • Feb 22, 2017: NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016
    • Feb 16, 2017: AroCell: (publ) Year-End Report
    • Feb 16, 2017: Almac Diagnostics Appoints Dr Leeona Galligan as Vice President UK Operations
    • Feb 15, 2017: Biocept Appoints Michael Terry Senior Vice President Commercial Operations
    • Feb 14, 2017: Genomic Health Announces 2016 Fourth Quarter and Year-End Financial Results, Provides 2017 Financial Outlook
    • Feb 08, 2017: MDxHealth Awarded US Department of Veterans Affairs Contract for ConfirmMDx Testing
    • Feb 07, 2017: Myriad Genetics Reports Fiscal Second-Quarter 2017 Financial Results
    • Feb 06, 2017: Ipsen announces appointment of Dr. Sotirios G. Stergiopoulos as Head of Global Medical Affairs
    • Feb 01, 2017: QIAGEN Reports Results for Fourth Quarter and Full-year 2016
    • Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017
    • Jan 27, 2017: Omega Diagnostics Group: Update on discussions with Immunodiagnostic Systems Holdings
    • Jan 26, 2017: Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017
    • Jan 26, 2017: Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services
    • Jan 26, 2017: Metabolon Announces Changes to Executive Leadership Team
    • Jan 24, 2017: AroCell: Research poster on prostate cancer has been accepted by the American Association for Cancer Research
    • Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results
    • Jan 20, 2017: Ipsen appoints Harout Semerjian as President, Head of Specialty Care International Region & Global Franchises
    • Jan 19, 2017: bioMerieux – Fourth-Quarter 2016 Business Review
    • Jan 19, 2017: Immunodiagnostic Systems Holdings Announces Directorate Change
    • Jan 18, 2017: MDxHealth Announces Horizon Blue Cross Blue Shield of New Jersey Issues Positive Coverage Policy on ConfirmMDx
    • Jan 18, 2017: Biomerica Announces Second Quarter Financial Results; Sales up Over 22% for the Quarter
    • Jan 18, 2017: Exosome Diagnostics Obtains ISO 15189 for Its Munich Laboratory
    • Jan 13, 2017: ProteoMediX receives ISO 13485:2012 Certification
    • Jan 11, 2017: Prostate Core Mitomic Test Significantly Reduces Unnecessary Biopsies, Improves Cancer Detection, New Study Says
    • Jan 09, 2017: MDxHealth Announces Preliminary Update on 2016 Results and Appointment of CFO
    • Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care
    • Jan 06, 2017: Cancer Genetics Announces Consolidation and Cost Reduction in Administrative and Operational Support Functions
    • Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team
    • Dec 19, 2016: OPKO Health to be Added to the NASDAQ Biotechnology Index
    • Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors
    • Dec 16, 2016: MDxHealth Receives ISO 13485:2016 Certification for Dutch Laboratory
    • Dec 15, 2016: Quest Diagnostics Board of Directors Elects Stephen H. Rusckowski Chairman of the Board
    • Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe
    • Dec 13, 2016: Study Demonstrates the Feasibility of Targeting Human Kallikrein-related Peptidase 2 for Detection and Monitoring of Prostate Cancer
    • Dec 12, 2016: Claude Bertrand to step down as Executive Vice President, R&D, Chief Scientific Officer of Ipsen
    • Dec 08, 2016: numares Opens Singapore Subsidiary to Expand Its Diagnostic System into Asia
    • Dec 08, 2016: DNA Methylation Biomarker for Prostate Cancer Shows Promise for Accurately Determining a Patients Risk
    • Dec 01, 2016: Arquer Diagnostics appoints new CEO
    • Dec 01, 2016: Arquer Diagnostics Appoints Nadia Whittley as CEO
    • Nov 30, 2016: New Imaging Method Can Detect, Monitor and Guide Treatment For, Prostate Cancer
    • Nov 25, 2016: Immunodiagnostic Systems Holdings: Interim Results for the six month period ended 30 September 2016
    • Nov 22, 2016: OGT announces commercial and financial highlights for FY 2016
    • Nov 17, 2016: AroCell: Interim report, 1 January – 30 September 2016
    • Nov 17, 2016: AroCell: Interim report January - September 2016
    • Nov 16, 2016: Epic Sciences Validates Single CTC Sequencing, Identifies Clonal Heterogeneity in Metastatic Cancer
    • Nov 14, 2016: Vermillion appoints chief medical officer
    • Nov 14, 2016: Arno Therapeutics Reports Third Quarter 2016 Financial and Business Update
    • Nov 11, 2016: Quest Diagnostics Raises Revenue Growth Outlook, Increases Dividend at 2016 Investor Day
    • Nov 11, 2016: GeneNews Announces Q3-2016 Financial Results and Provides Corporate Update
    • Nov 10, 2016: Cancer Genetics Announces Strong Third Quarter with 68% Year over Year Revenue Growth and Highlights Path to Future Profitability
    • Nov 10, 2016: Vermillion Reports Third Quarter 2016 Results
    • Nov 10, 2016: VolitionRx Announces Third Quarter 2016 Financial Results and Business Update
    • Nov 10, 2016: Almac Announce £27 million Global Expansion
    • Nov 09, 2016: Epigenomics Announces 2016 Third Quarter and Nine Months Financial Results and Reports on Operational Highlights
    • Nov 09, 2016: Biocept Reports 2016 Third Quarter Financial Results
    • Nov 08, 2016: Aeterna Zentaris Reports Third Quarter 2016 Financial and Operating Results
    • Nov 07, 2016: OPKO Health Reports Third Quarter Financial and Operating Results
    • Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux
    • Nov 07, 2016: Gene Signature Predicts Response to Radiation Therapy
    • Nov 04, 2016: Angle: Barts Research Supports Potential Use Of Parsortix
    • Nov 03, 2016: Geron Reports Third Quarter 2016 Financial Results and Recent Events
    • Nov 03, 2016: Ann Hammarstrand Appointed as New CFO to AroCell
    • Nov 02, 2016: MDxHealth Provides Third Quarter 2016 Business Update
    • Nov 02, 2016: QIAGEN Reports Results for Third Quarter and First Nine Months of 2016
    • Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016
    • Nov 02, 2016: QIAGEN launches restructuring initiatives, revises outlook for 2016 earnings and provides initial net sales and adjusted earnings guidance for 2017
    • Nov 01, 2016: Genomic Health Reports Third Consecutive Quarter of Double-Digit Revenue Growth in Announcement of Third Quarter 2016 Financial Results
    • Nov 01, 2016: Myriad Genetics Reports Fiscal First-Quarter 2017 Financial Results
    • Oct 31, 2016: MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
    • Oct 27, 2016: MDxHealth Announces Positive Coverage Policy with Fourth-Largest Health Insurer in the United States
    • Oct 27, 2016: Biocept Appoints David Moskowitz Vice President, Strategy & Corporate Communications
    • Oct 26, 2016: NeoGenomics Reports 142% Revenue Growth to $60.8 Million and a Record $9.6 Million in Cash Flow from Operations in the Third Quarter of 2016
    • Oct 24, 2016: ORYZON Reports Financial Results and Corporate Update for the 3rd Quarter Ended September 30, 2016
    • Oct 24, 2016: AltheaDx Announces Appointment of Chief Financial Officer
    • Oct 21, 2016: Immunodiagnostic Systems Holdings: H1 Trading Update
    • Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016
    • Oct 20, 2016: Quest Diagnostics Reports Third Quarter 2016 Financial Results
    • Oct 18, 2016: Biomerica Announces First Quarter Fiscal 2017 Financial Results, Sales Increase Over Prior Year
    • Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results
    • Oct 17, 2016: Arquer Diagnostics Provides Update on MCM5-ELISA test in Prostate Cancer
    • Oct 06, 2016: MDxHealth Reports Highmark Blue Cross Blue Shield Issues Positive Medical Policy On ConfirmMDx
    • Sep 29, 2016: Myriad Appoints Chip Parkinson as EVP for Reimbursement Strategy
    • Sep 28, 2016: MDxHealth and The European Health Centre Innovation Sign Distribution Agreement for ConfirmMDx in Poland
    • Sep 27, 2016: MDxHealth Announces Independence Blue Cross Rendered Positive Medical Coverage Policy for ConfirmMDx
    • Sep 26, 2016: Radiation Therapy and Radical Prostatectomy Further Explored for Initial Diagnosis of Advanced Prostate Cancer
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report